ArrayExpress Uploader0human5082arrayexpress_sid4Title: In vitro and in vivo effects of the orally bioavailable phenylbutyrate-derived histone deacetylase inhibitor OSU-HDAC42 on gene...E-GEOD-9974/profile/8773/arrayexpressuploader06adenocarcinomacancergenomehistoneDec.12, 2014FalseE-GEOD-9974_A-AFFY-44transcription-profiling-of-human-seg1-esophageal-cTranscription profiling of human SEG1 esophageal cell line treated with OSU-HDAC42, time seriesSep.22, 2014Title: In vitro and in vivo effects of the orally bioavailable phenylbutyrate-derived histone deacetylase inhibitor OSU-HDAC42 on gene expression in esophageal tissues and in esophageal adenocarcinoma cells; Histone deacetylases (HDACs) modulate nucleosomal packaging of DNA, thereby influencing gene transcription and multiple cancer-associated processes. Thus, we conducted microarray analysis at multiple time-points to assess the ability of OSU-HDAC42, the S enantiomer of the previously published compound HDAC-42, to modulate key acid-induced changes as well as to impact other genes altered as the normal esophageal epithelium progresses along the metaplasia-dysplasia-esophageal adenocarcinoma continuum. Experiment Overall Design: SEG-1 cells were pretreated for 24 hours with vehicle or OSU-HDAC42, pulsed with acidified media (pH 3.5; 20 mins at 37C), replenished with media or OSU-HDAC42, and harvested 3, 6 and 24 hours later. Global gene expression analysis was conducted using the human genome chip U133 2.0 Plus.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-9974http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-9974/samples/